Advertisement
ALVO vs EBS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVO is a Hold and EBS is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALVO’s FA Score shows that 0 FA rating(s) are green whileEBS’s FA Score has 1 green FA rating(s).
- ALVO’s FA Score: 0 green, 5 red.
- EBS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALVO’s TA Score shows that 4 TA indicator(s) are bullish while EBS’s TA Score has 4 bullish TA indicator(s).
- ALVO’s TA Score: 4 bullish, 4 bearish.
- EBS’s TA Score: 4 bullish, 3 bearish.
Price Growth
ALVO (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while EBS (@Pharmaceuticals: Other) price change was -0.68% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.92%. For the same industry, the average monthly price growth was +5.95%, and the average quarterly price growth was +72.47%.
Reported Earning Dates
ALVO is expected to report earnings on Nov 12, 2025.
EBS is expected to report earnings on Nov 05, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (+0.92% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| ALVO | EBS | ALVO / EBS | |
| Capitalization | 3.48B | 120M | 2,896% |
| EBITDA | -493.67M | -518.2M | 95% |
| Gain YTD | -34.014 | -23.849 | 143% |
| P/E Ratio | 57.47 | 17.73 | 324% |
| Revenue | 91.4M | 1.02B | 9% |
| Total Cash | 11.2M | 112M | 10% |
| Total Debt | 1.08B | 860M | 125% |
EBS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 11 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 56 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 94 | |
PRICE GROWTH RATING 1..100 | 49 | |
P/E GROWTH RATING 1..100 | 10 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ALVO | EBS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 67% | N/A |
| Stochastic ODDS (%) | 2 days ago 45% | 2 days ago 85% |
| Momentum ODDS (%) | 2 days ago 46% | 2 days ago 77% |
| MACD ODDS (%) | N/A | 2 days ago 72% |
| TrendWeek ODDS (%) | 2 days ago 55% | 2 days ago 88% |
| TrendMonth ODDS (%) | 2 days ago 64% | 2 days ago 76% |
| Advances ODDS (%) | 2 days ago 64% | 2 days ago 76% |
| Declines ODDS (%) | 8 days ago 67% | 4 days ago 89% |
| BollingerBands ODDS (%) | 2 days ago 64% | 2 days ago 80% |
| Aroon ODDS (%) | 2 days ago 67% | 2 days ago 88% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VHCAX | 203.09 | N/A | N/A |
| Vanguard Capital Opportunity Adm | |||
| EVTMX | 16.70 | N/A | N/A |
| Eaton Vance Dividend Builder A | |||
| IJSIX | 14.14 | N/A | N/A |
| VY® JPMorgan Small Cap Core Equity I | |||
| MSFLX | 34.38 | N/A | N/A |
| Morgan Stanley Inst Global Franchise L | |||
| PAAOX | 17.37 | N/A | N/A |
| T. Rowe Price Asia Opportunities Advisor | |||
ALVO and
Correlation & Price change
A.I.dvisor tells us that ALVO and EBS have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and EBS's prices will move in lockstep.
| Ticker / NAME | Correlation To ALVO | 1D Price Change % | ||
|---|---|---|---|---|
| ALVO | 100% | +3.68% | ||
| EBS - ALVO | 27% Poorly correlated | +4.15% | ||
| KMDA - ALVO | 25% Poorly correlated | -1.72% | ||
| PBH - ALVO | 25% Poorly correlated | -0.05% | ||
| RDY - ALVO | 23% Poorly correlated | +0.55% | ||
| PAHC - ALVO | 22% Poorly correlated | -2.65% | ||
More | ||||